TMEM100 and hepatocellular carcinoma: Then, to further verify this hypothesis, we analyzed the expression of TMEM100 in ANLTs, well differentiated hepatocellular carcinoma and poorly differentiated hepatocellular carcinoma by immunohistochemistry.